Pasithea Therapeutics Corp (KTTA) — Tangible Net Worth Ratio
Pasithea Therapeutics Corp (KTTA) has a Tangible Net Worth Ratio of 44.0% as of September 2025. This metric is calculated by deducting intangible assets ($6.84 Million) from net assets ($12.21 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See KTTA net asset value for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Pasithea Therapeutics Corp Tangible Net Worth Ratio (2020–2024)
This chart shows how Pasithea Therapeutics Corp's Tangible Net Worth Ratio has changed across 5 annual periods from 2020 to 2024. As of September 2025, the ratio stands at 44.0%, reflecting net assets of $12.21 Million with intangible assets of $6.84 Million USD. Also explore Pasithea Therapeutics Corp net asset momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Pasithea Therapeutics Corp (2020–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Pasithea Therapeutics Corp from 2020 to 2024, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Pasithea Therapeutics Corp market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 50.5% | $14.78 Million | $7.31 Million | $16.06 Million | ▼ -15.5 pp |
| 2023 | 66.1% | $23.40 Million | $7.94 Million | $26.12 Million | ▼ -13.8 pp |
| 2022 | 79.8% | $42.50 Million | $8.57 Million | $45.18 Million | ▼ -20.2 pp |
| 2021 | 100.0% | $51.42 Million | $0.00 | $53.32 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $241.35K | $0.00 | $247.96K | — |